Workflow
美诺华: 宁波美诺华药业股份有限公司关于撤销监事会并修订《公司章程》的公告

Core Viewpoint - Ningbo Meinuohua Pharmaceutical Co., Ltd. plans to abolish its supervisory board and amend its articles of association, transferring the supervisory responsibilities to the audit committee of the board of directors, pending approval from the shareholders' meeting [1][2]. Group 1: Company Structure Changes - The company has passed a resolution to abolish the supervisory board and amend the articles of association in accordance with relevant laws and regulations [1]. - The supervisory responsibilities defined in the Company Law will be assumed by the audit committee after the amendments are approved [1][2]. - The current supervisory board will continue to fulfill its duties until the new articles of association come into effect [1]. Group 2: Amendments to Articles of Association - The amendments include changes to the terminology, such as replacing "shareholders' meeting" with "shareholders' assembly" [2]. - The registered capital of the company remains at RMB 21 million, and the total number of shares is 219,822,861, all of which are ordinary shares [2]. - The amendments also clarify the roles of the legal representative and the responsibilities of the board of directors and senior management [2][4]. Group 3: Governance and Compliance - The company emphasizes the need for compliance with laws and regulations in its governance structure, ensuring that the rights and obligations of shareholders are clearly defined [2][18]. - The articles of association will serve as a binding document for the company, shareholders, directors, and senior management, allowing for legal actions among these parties [2][18]. - The company will ensure that any financial assistance provided for share purchases will not exceed 10% of the total issued capital [2][8].